Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease
Digestive and Liver Diseases Feb 16, 2018
Vasudevan A, et al. - The utility and tolerability of thiopurine-allopurinol co-therapy were evaluated in inflammatory bowel disease (IBD) patients with intolerance to thiopurine monotherapy. In overcoming intolerances to thiopurine monotherapy in many cases, low-dose thiopurine combined with allopurinol appeared safe and effective.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
